Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms

Despite increasing treatment options, multiple myeloma (MM) remains incurable for most patients. Data on improvement of outcomes are derived from selected patient populations enrolled in clinical trials and might not be conferrable to all patients. Therefore, we assessed the trial eligibility, seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Knauf, Wolfgang, Aldaoud, Ali, Hutzschenreuter, Ulrich, Klausmann, Martine, Dille, Stephanie, Wetzel, Natalie, Jänicke, Martina, Marschner, Norbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208687/
https://www.ncbi.nlm.nih.gov/pubmed/30069704
http://dx.doi.org/10.1007/s00277-018-3449-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208687/
https://www.ncbi.nlm.nih.gov/pubmed/30069704
http://dx.doi.org/10.1007/s00277-018-3449-8

Ejemplares similares